cilazapril, anhydrous has been researched along with Disease Exacerbation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Chiang, WC; Chien, CT; Lin, SL; Tsai, CC; Tsai, TJ | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Futrakul, N; Futrakul, P; Kingwatanakul, P; Sensirivatana, R; Sitprija, V; Watana, D | 1 |
| Momma, K; Mori, Y; Nakazawa, M; Tomimatsu, H | 1 |
2 trial(s) available for cilazapril, anhydrous and Disease Exacerbation
| Article | Year |
|---|---|
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan | 2008 |
Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Insufficiency; Child; Child, Preschool; Cilazapril; Disease Progression; Echocardiography; Enalapril; Follow-Up Studies; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Infant; Mitral Valve Insufficiency; Myocardial Contraction; Observer Variation; Pilot Projects; Treatment Outcome; Ventricular Function, Left | 2000 |
2 other study(ies) available for cilazapril, anhydrous and Disease Exacerbation
| Article | Year |
|---|---|
Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Division; Cells, Cultured; Chemokine CCL2; Cilazapril; Disease Progression; Down-Regulation; Fibroblasts; Fibrosis; Gene Expression; Glomerular Mesangium; Kidney; Kidney Diseases; Male; Mitosis; Muscle, Smooth; Nephrectomy; Nephritis; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar | 2002 |
Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
Topics: Cilazapril; Dipyridamole; Disease Progression; Glomerulosclerosis, Focal Segmental; Heparin; Humans; Isradipine; Perfusion; Prednisolone; Renal Circulation | 1995 |